US2011034397A1PendingUtilityA1
Intestinal immune system stimulator
Est. expiryFeb 15, 2028(~1.6 yrs left)· nominal 20-yr term from priority
A61P 35/00A61P 37/04A61P 31/00A61P 37/08A61P 1/00A23L 33/18A61P 1/04A23L 33/10A61P 1/12A61K 38/05Y02A50/30
30
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed is an agent, γ-glutamylcysteine, which can effectively and safely stimulate the intestinal immune system. γ-Glutamylcysteine can be formulated in a pharmaceutical composition, a food, and/or a beverage, and used for the treatment or prevention of infectious diseases, diarrhea, polyps, tumors, enteritis or allergy.
Claims
exact text as granted — not AI-modified1 . A method for stimulating the intestinal immune system in a subject in need of stimulation of the intestinal immune system comprising administering a composition comprising γ-glutamylcysteine to the subject.
2 . The method of claim 1 , wherein said γ-glutamylcysteine is present in the composition in an amount of 0.000001% or more by mass.
3 . A method for treating or preventing a condition selected from the group consisting of an infection, diarrhea, polyp, tumor, enteritis, allergy, and combinations thereof, said method comprising administering a composition comprising γ-glutamylcysteine to a subject having said condition.
4 . The method of claim 3 , wherein said γ-glutamylcysteine is present in said composition in an amount of 0.000001% or more by mass.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.